141 related articles for article (PubMed ID: 28952976)
21. Interactions between opioids and cannabinoids: Economic demand for opioid/cannabinoid mixtures.
Maguire DR; France CP
Drug Alcohol Depend; 2020 Jul; 212():108043. PubMed ID: 32497977
[TBL] [Abstract][Full Text] [Related]
22. Effect of daily morphine administration and its discontinuation on delay discounting of food in rhesus monkeys.
Maguire DR; Gerak LR; France CP
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):155-64. PubMed ID: 26397762
[TBL] [Abstract][Full Text] [Related]
23. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin.
Stevenson GW; Folk JE; Rice KC; Negus SS
J Pharmacol Exp Ther; 2005 Jul; 314(1):221-31. PubMed ID: 15792997
[TBL] [Abstract][Full Text] [Related]
24. The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.
Wang Y; Yin F; Guo H; Zhang J; Yan P; Lai J
Int J Neuropsychopharmacol; 2017 Jul; 20(7):562-574. PubMed ID: 28199666
[TBL] [Abstract][Full Text] [Related]
25. Effects of the synthetic cannabinoid receptor agonist JWH-018 on abuse-related effects of opioids in rhesus monkeys.
Gerak LR; Weed PF; Maguire DR; France CP
Drug Alcohol Depend; 2019 Sep; 202():33-38. PubMed ID: 31295696
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT
McLaughlin PJ; Jagielo-Miller JE; Plyler ES; Schutte KK; Vemuri VK; Makriyannis A
Psychopharmacology (Berl); 2017 Mar; 234(6):1029-1043. PubMed ID: 28144708
[TBL] [Abstract][Full Text] [Related]
27. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys.
Winger G; Woods JH
Drug Alcohol Depend; 2001 May; 62(3):181-9. PubMed ID: 11295322
[TBL] [Abstract][Full Text] [Related]
28. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
Trang T; Sutak M; Jhamandas K
Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
[TBL] [Abstract][Full Text] [Related]
29. Daily morphine administration increases impulsivity in rats responding under a 5-choice serial reaction time task.
Maguire DR; Henson C; France CP
Br J Pharmacol; 2016 Apr; 173(8):1350-62. PubMed ID: 26776751
[TBL] [Abstract][Full Text] [Related]
30. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
[TBL] [Abstract][Full Text] [Related]
31. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.
Biscaia M; Fernández B; Higuera-Matas A; Miguéns M; Viveros MP; García-Lecumberri C; Ambrosio E
Neuropharmacology; 2008 Apr; 54(5):863-73. PubMed ID: 18329053
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
33. Punishment and reinforcement by opioid receptor agonists in a choice procedure in rats.
Minervini V; Osteicoechea DC; Casalez A; France CP
Behav Pharmacol; 2019 Jun; 30(4):335-342. PubMed ID: 30320606
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
35. Effect of a selective GABA(B) receptor agonist baclofen on the mu-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects.
Suzuki T; Nurrochmad A; Ozaki M; Khotib J; Nakamura A; Imai S; Shibasaki M; Yajima Y; Narita M
Neuropharmacology; 2005 Dec; 49(8):1121-31. PubMed ID: 16095635
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors and TRPV1 channels.
Fatahi Z; Reisi Z; Rainer G; Haghparast A; Khani A
Neuropharmacology; 2018 May; 133():75-84. PubMed ID: 29355640
[TBL] [Abstract][Full Text] [Related]
37. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
38. Methocinnamox (MCAM) antagonizes the behavioral suppressant effects of morphine without impairing delayed matching-to-sample accuracy in rhesus monkeys.
Minervini V; Disney A; Husbands SM; France CP
Psychopharmacology (Berl); 2020 Oct; 237(10):3057-3065. PubMed ID: 32772146
[TBL] [Abstract][Full Text] [Related]
39. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
[TBL] [Abstract][Full Text] [Related]
40. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
Negus SS; Gatch MB; Mello NK
Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]